Early research (Phase 1)Ended earlyNCT05859724
What this trial is testing
Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD)
Who this might be right for
Atopic Dermatitis
Yellow Jersey Therapeutics AG 126